Mitogen-Activated Protein Kinase Inhibitors and T-Cell-Dependent Immunotherapy in Cancer is a research paper published in Pharmaceuticals (2020). On theSindex it has a DataRank of 0. It has been cited 37 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Department of Veterans Affairs
Grant: BX002703
U.S. Department of Veterans Affairs
Grant: BX003296
National Cancer Institute
Grant: CA 216410
National Cancer Institute
Grant: CA 176846
National Cancer Institute
Grant: CA178063
National Institutes of Health
Grant: 1F30CA236031
NCI NIH HHS
Grant: F30 CA236031
BLRD VA
Grant: I01 BX003296
NCI NIH HHS
Grant: R01 CA178063
National Institutes of Health
Grant: 5R01CA216410-04
Developing Nano Technology for HER2 Directed Therapy
National Institutes of Health
Grant: 5F30CA236031-02
Augmenting Pancreatic Cancer Immunotherapy via TGFβ Pathway Inhibition
National Institutes of Health
Grant: 7R01CA176846-04
Oncogenic MLK3-Pak1 Signaling in ER Negative Breast Cancer
FWCI
1.72
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals